About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ARNA - Arena Pharmaceutical...| Previous Close | $60.48 | Open | $61.19 |
| Volume | 403.9K | Market Cap | 3.671B |
| Yield | Last Dividend |
| Narcolepsy Drugs Market to Reach Valuati... | 03/10/21 |
| Increase in prevalence of narcolepsy across the globe, surge in narcolepsy awareness programs, and presence of reimbursement policies regarding narcol... | |
| Arena Pharma's Olorinab Fails To Top Pla... | 03/03/21 |
| Arena Pharmaceuticals Inc (NASDAQ: ARNA) has announced topline data from Phase 2b CAPTIVATE trial evaluating olorinab for ??? | |
| Arena Pharmaceuticals Reports Topline Re... | 03/02/21 |
| PARK CITY, Utah--(BUSINESS WIRE)---- $ARNA #ArenaPharm--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced topline results from the randomized... | |
| Arena Reports Fourth Quarter Financial R... | 02/23/21 |
| SAN DIEGO--(BUSINESS WIRE)---- $ARNA #ArenaPharm--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial ... | |
| The Week Ahead In Biotech: J&J Vaccine A... | 02/20/21 |
| Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before picking up pa... | |
| Arena Pharmaceuticals Reports Inducement... | 02/18/21 |
| SAN DIEGO--(BUSINESS WIRE)--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on February 15, 2021, the Compensation Committee of its Bo... | |
| Arena Pharmaceuticals to Release Fourth ... | 02/16/21 |
| SAN DIEGO--(BUSINESS WIRE)---- $ARNA #earnings--Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corpora... | |
| Arena Pharmaceuticals Announces Changes ... | 02/16/21 |
| SAN DIEGO--(BUSINESS WIRE)-- #ArenaPharm--Industry veteran Garry Neil, MD named Board Chair. Nawal Ouzren, CEO of Sensorion named to Board. | |
| Anti Obesity Drugs Market Consumption 20... | 02/11/21 |
| Stratagem Market Insights offer in-depth analysis concerning the complete Anti Obesity Drugs Market position and Recent Trends. It involves the examin... | |
| Arena Pharmaceuticals Completes Full Enr... | 02/02/21 |
| SAN DIEGO--(BUSINESS WIRE)---- $ARNA--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has completed full enrollment of the Phase 3 ... | |
| Insider Selling: Arena Pharmaceuticals, ... | 01/21/21 |
| Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Director Jayson Donald Alexander Dallas sold 1,327 shares of Arena Pharmaceuticals stock in a transaction th... | |
| Anti-obesity Drugs Market: The Next Big ... | 12/15/20 |
| The global Anti-obesity Drugs market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive... | |
| Arena Pharmaceuticals to Present Data fr... | 12/11/20 |
| SAN DIEGO, Dec. 11, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that data from the Phase 2b ADVISE trial evaluatin... | |
| Cannabis Stock Gainers And Losers From D... | 12/08/20 |
| GAINERS: iAnthus Capital Hldgs (PINK: ITHUF ) shares closed up 24% at $0.31 22nd Century Group, Inc. Common Stock (AMEX: XXII) shares closed up 21.15%... | |
| Arena Pharmaceuticals Achieves Target En... | 12/08/20 |
| SAN DIEGO, Dec. 8, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has achieved its targeted enrollment goal o... | |
| Arena Pharmaceuticals to Present at the ... | 11/24/20 |
| SAN DIEGO, Nov. 24, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and C... | |
| Arena Pharmaceuticals (NASDAQ:ARNA) Rece... | 11/20/20 |
| Smith Barney Citigroup assumed coverage on shares of Arena Pharmaceuticals (NASDAQ:ARNA) in a research report sent to investors on Thursday, The Fly r... | |
| Arena Pharmaceuticals (NASDAQ:ARNA) Now ... | 11/20/20 |
| Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell began coverage on shares of Arena Pharmaceuticals (NASDAQ:ARNA) in a research ... | |
| Arena Reports Third Quarter Financial Re... | 11/09/20 |
| SAN DIEGO, Calif., Nov. 9, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial re... | |
| Arena Pharmaceuticals Earnings Report: H... | 11/09/20 |
| Arena Pharmaceuticals announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Arena Pharmaceuticals Q3 2020 Earnings P... | 11/08/20 |
| Arena Pharmaceuticals (NASDAQ:ARNA) is scheduled to announce Q3 earnings results on Monday, November 9th, after market close. The consensus EPS Estima... | |
| Earnings Preview for Arena Pharmaceutica... | 11/06/20 |
| Arena Pharmaceuticals (NASDAQ: ARNA) unveils its next round of earnings this Monday, November 09. Here is Benzinga's everything-that-matters guide ??? | |
| The Daily Biotech Pulse: Bluebird Bio Pl... | 11/05/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbo... | |
| Cannabis Stock Gainers And Losers From N... | 11/04/20 |
| GAINERS : Innovative Industrial (NYSE: IIPR ) shares closed up 8.46% at $133.47 Teradyne (NASDAQ: TER ) shares closed up 6.7% at $95.85 Cansortium (OT... | |
| Arena Pharmaceuticals to Release Third Q... | 11/02/20 |
| SAN DIEGO, Nov. 2, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its third quarter 2020 financial results and provide a... | |
| Arena Pharmaceuticals Announces Launch o... | 10/28/20 |
| /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), and Longboard Pharmaceuticals, Inc., today announced the launch of Longboard Pharmaceutica... | |
| Pharmaceutical Grade Marijuana: Market |... | 10/27/20 |
| Pharmaceutical Grade Marijuana Market 2020 this report is including with the COVID19 Outbreak Impact analysis of key points influencing the growth of ... | |
| Cannabis Stock Gainers And Losers From O... | 10/26/20 |
| GAINERS: AusCann Group Holdings (OTCQX: ACNNF ) shares closed up 10.53% at $0.11 Item 9 Labs (OTCQX: INLB ) shares closed up 7.48% at $1.15 Arena Phar... | |
| Cannabis Stock Gainers And Losers From O... | 10/22/20 |
| GAINERS: BioHarvest Sciences (PINK: CNVCF) shares closed up 13.64% at $0.13 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 10.5% at $1.04 Nex... | |
| Arena Pharmaceuticals (NASDAQ:ARNA) Stoc... | 10/21/20 |
| Arena Pharmaceuticals (NASDAQ:ARNA) was downgraded by equities researchers at BidaskClub from a ???strong-buy??? rating to a ???buy??? rating in a rep... | |
| Buy rating | 04/27/21 |
| Citigroup initiates coverage with Buy rating and announces Price Target of $104.00 | |
| Strong Buy rating | 04/13/21 |
| Credit Suisse maintains Outperform rating and raises Price Target from $87.00 to $102.00 | |
| Buy rating | 03/26/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $90.00 to $120.00 | |
| Strong Buy rating | 03/03/21 |
| Cantor Fitzgerald maintains Overweight rating and lowers Price Target from $106.00 to $100.00 | |
| Strong Buy rating | 02/24/21 |
| SVB Leerink maintains Outperform rating and lowers Price Target from $92.00 to $90.00 | |
| Date | 2021-02-23 (AMC) | Est. (EPS/Rev.) | ($1.85)/ 560K |
| Actual (EPS/Rev.) | $-2.10/ $37.00 K | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Trading Systems | Trading Systems | 83.00 % | Subscribe |
| Best Trading Ideas | Best Trading Ideas | 53.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
